openPR Logo
Press release

AIDS-Related Opportunistic Infections Market to Register a Stout Growth by 2014 – 2020

12-05-2017 11:24 AM CET | Health & Medicine

Press release from: Transparency Market Research

AIDS-Related Opportunistic Infections Market to Register

The Acquired Immune Deficiency Syndrome (AIDS) is caused by a virus know as Human Immunodeficiency Virus (HIV). This virus attacks the immune system (CD4 cells) and exposes an individual to host opportunistic infections. The infections acquired by an individual when his immune defenses are low are termed as opportunistic infections. These infections generally do not affect healthy persons while the immunocompromised patients are the softest targets for such infections. The attack of these infections was more frequent and more severe in the past before beginning of the widespread use of potent combination of antiretroviral therapy (ART). However, with the advent of ARTs there has been noteworthy reduction in mortality rate of HIV patients and reduction in risk of AIDS-related opportunistic infections.

Report Overview and TOC: https://www.transparencymarketresearch.com/aids-related-opportunistic-infections-market.html

The most common opportunistic infections in HIV positive people are Candidiasis, Cytomegalovirus (CMV), Cryptococcosis, Cryptosporidiosis, Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (TB), Pneumocystis pneumonia (PCP), Progressive multifocal leukoencephalopathy (PML) and Toxoplasmosis (Toxo). A person’s T cell or CD4 count determines his/her risk for certain opportunistic infections. It is therefore necessary that medications are used to boost the CD4 cells. The use adoption of standard antiretroviral therapy (ART) consisting of combination of at least three antiretroviral (ARV) drugs have been proven beneficial in suppressing the HIV virus and halting the progressing of HIV disease.

The very first class of drugs used as antiretroviral therapy was nucleoside reverse transcriptase inhibitors (also called NRTIs). The major drugs in this class include zidovudine, didanosine, stavudine, lamivudine, abacavir, tenofovir, emtricitabine. Non-nucleoside reverse transcriptase inhibitors and integrase inhibitors constitute other classes of ART drugs. If the patient population is not engaged in ART therapy or other preventive measures such as vaccination programs and prophylaxis, AID-related opportunistic infections are bound to occur. Some of the major AIDS-related opportunistic infections and their recommended treatment drugs include Pneumocystis Jiroveci Pneumonia (Trimethoprim-sulfamethoxazole), Toxoplasma gondii Encephalitis (pyrimethamine, sulfadiazine and leucovorin), Cryptosporidiosis (Paromomycin), Mycobacterium tuberculosis Disease (Isoniazid, rifampin, ethambutol, pyrazinamide and DOTS therapy), Mycobacterium avium Complex Disease (Clarithromyci and azithromycin),and bacterial pneumonia (levofloxacin, moxifloxacin, or gatifloxacin).

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3760

On the basis of geography, the global AIDS-related opportunistic infections market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Middle East, Africa and Latin America. The highly priced branded drugs are sold in markets such as North America and Europe which formulates them into global leader in the overall AIDs-related market. Despite the availability of antiretroviral therapy in the developed nations such as United States, the AIDS-related opportunistic infections are causing significant morbidity and mortality. The disease is more serious in other regions, particularly in Africa. Of the estimated 34.2 million HIV-infected individuals worldwide, more than 22.9 million people are from Sub-Saharan Africa and represent continuous demand for HIV/AIDS treatment drugs.

For Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3760

The patients in these low- and middle-income countries of other regions were earlier deprived of the antiretroviral therapy or HIV treatment due to high costs of therapy. However, with the increasing production of generic drugs in countries like India, the treatment cost has reduced drastically and have helped in improved uptake of antiretroviral therapy in these countries. In 2011, more than 8 million received ARV therapy which represents significant growth in supply of this therapy drugs. The WHO recommendation for ARV usage for prevention of HIV infection, particularly for pregnant women, young children and other population with HIV risk is expected to further drive the drugs market for AID-related opportunistic infections.

Some of major companies in the global AIDS-related opportunistic infections market include ViiV Healthcare, Gilead Sciences, Inc., Bristol-Myers Squibb Co., Merck & Co., Johnson & Johnson, Pfizer, Inc., GlaxoSmithKline plc, and Janssen Therapeutics.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=3760<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AIDS-Related Opportunistic Infections Market to Register a Stout Growth by 2014 – 2020 here

News-ID: 845378 • Views: 100

More Releases from Transparency Market Research

Global Genome Engineering Market: Business Growth, Development Factors, Applicat …
TMR’s report on the global genome engineering market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global genome engineering market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth
Sintering Process Market Growth Trends, Current Demand, and Development Report
Global Sintering Process Market: Snapshot The global sintering process market is prophesied to gain largely from the competent flourish of powder metallurgy and its applications in a range of industries. Power metallurgy-based process routes incorporating hot isostatic pressing (HIP) and exceptionally good properties are mainly employed in land-based and aero-engine gas turbine applications. Titanium powder metallurgy gathers a growing interest in the airframe industry for weight reduction in replacement steel parts
Medical Textiles Market Report Analysis: Emerging Trends, Business Growth Opport …
Global Medical Textiles Market: Snapshot The global medical textiles market is growing on the back of plethora of reasons. The government bodies of many worldwide countries have introduced diverse stringent regulations that compel the use of medical textiles. At the same time, these government organizations are offering financial support for non-implantable goods. These factors are working as key drivers for the development of the global medical textiles market. An upcoming research report
Anti-Hypertensive Drugs Market Industry Analysis Size, Share, Trend, Business Op …
Global Anti-Hypertensive Drugs Market: Overview Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. At rest blood pressure level is in the range of 120-140 mm Hg systolic and 60-90mm Hg diastolic. Hypertension arises when it is persistently

All 5 Releases


More Releases for AIDS

3rd Annual Summit on AIDS
We are delightful to welcome you to the “3rd Annual Summit on AIDS” which is going to be scheduled on September 16-17, 2019 at Singapore. This conference is a global platform for AIDS Disease Professionals where we assure you to have knowledge with scholars from around the world for the best current strategies for diagnosis and treatment of AIDS. AIDS 2019 is based on the theme of ENHANCING COMPETENCY IN
AIDS-related Kaposi’s Sarcoma Market Report 2017
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
Global HIV-AIDS Testing Market
The HIV-AIDS Testing Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that
Global Hearing Aids Market 2016: Digital hearing aids, Analog hearing aids
A hearing aid is an electronic device that amplifies the sound resulting in the production of clear sound for the user. These are largely deployed for people who suffer from hearing loss and impairment. The global Hearing aids market is gaining popularity owing to the rising technological innovations and increased demand for aesthetic designs of the devices. While the market is considered to be influenced by factors such as technological
BOLIVIA VOLUNTEERS aids flood victims.
In response to the severe flooding in the city, caused by the highest levels of torrential rainfall recorded for many years, BOLIVIA VOLUNTEERS has sent four of its volunteers currently in COCHABAMBA to help individuals, displaced families and the community. Liaising with community leaders, the volunteers are providing immediate emergency assistance in a variety of ways, to try to help ease the devastating impact the recent floods have had. Recent flash-floods
All Hearing Aids, All Here
The struggle to research hearing aids is now as easy as a point and a click. Featuring unbiased information in an easy to understand format, AdviceOnHearingAids.com is an educational forum designed to help those with hearing loss find the best aid for their unique challenges. Audiologist owned and operated, AdviceOnHearingAids features information about the latest in hearing aid technology. "The hearing aid industry has its own language, and that can